| 住院患者使用利奈唑胺注射液安全性的前瞻性研究 |
| |
| 引用本文： | 杨赛成,牟琼雅,王石健,王金明,王彬辉.住院患者使用利奈唑胺注射液安全性的前瞻性研究[J].辽宁药物与临床,2013(10):950-952. |
| |
| 作者姓名： | 杨赛成 牟琼雅 王石健 王金明 王彬辉 |
| |
| 作者单位： | [1]台州市立医院药剂科,浙江,台州,318000;浙江中医药大学,杭州,310053 [2]温州医学院仁济学院,浙江温州325035 [3]台州市立医院药剂科,浙江台州318000 |
| |
| 基金项目： | 2011年浙江省药学会医院药学科研专项基金项目（2011zyy15） |
| |
| 摘 要： | 目的 了解住院患者使用利奈唑胺注射液的不良反应（ADR）发生情况与类型.方法 前瞻性观察2011-2012年56例住院患者使用利奈唑胺注射液后ADR的发生情况.结果 共发生ADR 17例（30.3%）;总ADR发生率与年龄、性别无关;ADR主要表现为血小板减少（47.2%）,其次为腹泻、皮疹、精神异常（均为11.7%）,罕见药物热、癫（癎）、肝功能异常（均为5.9%）.结论 利奈唑胺注射液使用期间,应密切监测其不良反应,及时进行相关实验室检查,以确保患者用药安全.
|
| 关 键 词： | 利奈唑胺 不良反应 前瞻性研究 |
A prospective study on the safety of linezolid injection in inpatients |
| |
| YANG Sai-cheng,MOU Qiong-ya,WANG Shi-jian,WANG Jin-ming,WANG Bin-hui.A prospective study on the safety of linezolid injection in inpatients[J].Liaoning Pharmacy and Clinical Remedies,2013(10):950-952. |
| |
| Authors: | YANG Sai-cheng MOU Qiong-ya WANG Shi-jian WANG Jin-ming WANG Bin-hui |
| |
| Institution: | 1. Department of Pharmacy, Taizhou Municipal Hospital, Taizhou 318000, China; 2. Zhejiang Chinese Medical University, Hangzhou 310053, China; 3. Renji College, Wenzhou Medical University, Wenzhou 325035, China) |
| |
| Abstract: | Objective To explore the adverse reactions （ADR）of linezolid injection. Methods The ADR of 56 inpatients received linezolid injection in our hospital from 2011 to 2012 were prospectively observed. Results There were 17 cases of ADR（34. 7% ）. The total ADR rates had no relation with age or sex. Clinical presentations of ADR mainly referred to thrombopenia （47.2 % ）, secondly for diarrhea, skin eruption, mental disorder （11.7 % respectively）, the drug fever, epilepsy and abnormal liver function counted for 5.9% respectively. Conclusion The ADR of linezolid injection should be monitored closely in clinic, and the laboratory tests should be done in time to make sure the drug safety for patients. |
| |
| Keywords: | Linezolid ADR Prospective study |
| 本文献已被 维普 等数据库收录！ |
|
